FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

15505211000001103: Lisinopril 10mg / Hydrochlorothiazide 12.5mg tablets 30 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
54850501000001119 Lisinopril 10mg / Hydrochlorothiazide 12.5mg tablets 30 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
54850601000001115 Lisinopril 10mg / Hydrochlorothiazide 12.5mg tablets 30 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

2 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lisinopril 10mg / Hydrochlorothiazide 12.5mg tablets 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Lisinopril 10mg / Hydrochlorothiazide 12.5mg tablets 30 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Lisinopril 10mg / Hydrochlorothiazide 12.5mg tablets 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Lisinopril 10mg / Hydrochlorothiazide 12.5mg tablets 30 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Lisinopril 10mg / Hydrochlorothiazide 12.5mg tablets 30 tablet Has VMP Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 10 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Lisinopril 10mg / Hydrochlorothiazide 12.5mg tablets 30 tablet Has specific active ingredient Hydrochlorothiazide true Inferred relationship Existential restriction modifier
Lisinopril 10mg / Hydrochlorothiazide 12.5mg tablets 30 tablet Has specific active ingredient Lisinopril true Inferred relationship Existential restriction modifier
Lisinopril 10mg / Hydrochlorothiazide 12.5mg tablets 30 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Zestoretic 10 tablets (Waymade Healthcare Plc) 30 tablet Is a True Lisinopril 10mg / Hydrochlorothiazide 12.5mg tablets 30 tablet Inferred relationship Existential restriction modifier
Zestoretic 10 tablets (Sigma Pharmaceuticals Plc) 30 tablet Is a True Lisinopril 10mg / Hydrochlorothiazide 12.5mg tablets 30 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start